Clinical presentation, risk factors and staging systems of cholangiocarcinoma

Carriaga, 1995, Liver, gallbladder, extrahepatic bile ducts, and pancreas, Cancer, 75, 171, 10.1002/1097-0142(19950101)75:1+<171::AID-CNCR2820751306>3.0.CO;2-2

Gatto, 2010, New insights on cholangiocarcinoma, World J Gastrointest Oncol, 15, 36

Welzel, 2006, Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States, J Natl Cancer Inst, 98, 873, 10.1093/jnci/djj234

Shaib, 2004, Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?, J Hepatol, 40, 472, 10.1016/j.jhep.2003.11.030

DeOliveira, 2007, Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution, Ann Surg, 245, 755, 10.1097/01.sla.0000251366.62632.d3

Alvaro, 2011, Cholangiocarcinoma in Italy: a national survey on clinical characteristics, diagnostic modalities and treatment. Results from the “Cholangiocarcinoma” committee of the Italian Association for the Study of Liver disease, Dig Liver Dis, 43, 60, 10.1016/j.dld.2010.05.002

Tyson, 2011, Risk factors for cholangiocarcinoma, Hepatology, 54, 173, 10.1002/hep.24351

Khan, 2012, Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update, Gut, 61, 1657, 10.1136/gutjnl-2011-301748

Boberg, 2011, Primary sclerosing cholangitis and malignancy, Best Pract Res Clin Gastroenterol, 25, 753, 10.1016/j.bpg.2011.10.002

Ehlken, 2013, Primary sclerosing cholangitis and cholangiocarcinoma: pathogenesis and modes of diagnostics, Dig Dis, 31, 118, 10.1159/000347206

Chalasani, 2000, Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter study, Hepatology, 31, 7, 10.1002/hep.510310103

Bergquist, 2002, Hepatic and extrahepatic malignancies in primary sclerosing cholangitis, J Hepatol, 36, 321, 10.1016/S0168-8278(01)00288-4

Boberg, 2002, Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation, Scand J Gastroenterol, 37, 1205, 10.1080/003655202760373434

Burak, 2004, Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis, Am J Gastroenterol, 99, 523, 10.1111/j.1572-0241.2004.04067.x

Claessen, 2009, High lifetime risk of cancer in primary sclerosing cholangitis, J Hepatol, 50, 158, 10.1016/j.jhep.2008.08.013

Rosen, 1991, Cholangiocarcinoma complicating primary sclerosing cholangitis, Ann Surg, 213, 21, 10.1097/00000658-199101000-00004

Erichsen, 2009, Incidence and prognosis of cholangiocarcinoma in Danish patients with and without inflammatory bowel disease: a national cohort study, 1978-2003, Eur J Epidemiol, 24, 513, 10.1007/s10654-009-9365-4

Chapman, 2010, Diagnosis and management of primary sclerosing cholangitis, Hepatology, 51, 660, 10.1002/hep.23294

Rupp, 2014, Risk factors and outcome in patients with primary sclerosing cholangitis with persistent biliary candidiasis, BMC Infect Dis, 23, 562, 10.1186/s12879-014-0562-8

Shaib, 2004, The epidemiology of cholangiocarcinoma, Semin Liver Dis, 24, 115, 10.1055/s-2004-828889

Okuda, 2002, Cholangiocarcinoma: recent progress. Part 1: epidemiology and etiology, J Gastroenterol Hepatol, 17, 1049, 10.1046/j.1440-1746.2002.02781.x

Tabrizian, 2012, Hepatic resection for primary hepatolithiasis: a single-center Western experience, J Am Coll Surg, 215, 622, 10.1016/j.jamcollsurg.2012.07.005

Guglielmi, 2014, Hepatolithiasis-associated cholangiocarcinoma: results from a multi-institutional national database on a case series of 23 patients, EJSO, 40, 567, 10.1016/j.ejso.2013.12.006

Sheen-Chen, 1991, Intrahepatic cholangiocarcinoma in epatolithiasis: a frequently overlooked disease, J Surg Oncol, 47, 131, 10.1002/jso.2930470213

Zen, 2006, J Hepatol, 44, 350, 10.1016/j.jhep.2005.09.025

Lee, 2008, Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study, Am J Gastroenterol, 103, 1716, 10.1111/j.1572-0241.2008.01796.x

Zhou, 2008, Risk factors for intrahepatic cholangiocarcinoma: a case-control study in China, World J Gastroenterol, 14, 632, 10.3748/wjg.14.632

Huang, 2005, Relation of hepatolithiasis tohelminthic infestation, J Gastroenterol Hepatol, 20, 141, 10.1111/j.1440-1746.2004.03523.x

Liu, 2011, Risk factors of intrahepatic cholangiocarcinoma in patients with hepatolithiasis: a case control study, Hepatobiliary Pancreat Dis Int, 10, 626, 10.1016/S1499-3872(11)60106-9

Schottenfeld, 2006, Chronic inflammation: a common and important factor in the pathogenesis of neoplasia, CA Cancer J Clin, 56, 69, 10.3322/canjclin.56.2.69

Welzel, 2007, Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case-control study, Int J Cancer, 120, 638, 10.1002/ijc.22283

Abdalla, 1999, Monolobar Caroli's disease and cholangiocarcinoma, HPB Surg, 11, 271, 10.1155/1999/70985

Chapman, 1999, Risk factors for biliary tract carcinogenesis, Ann Oncol, 10, 308, 10.1093/annonc/10.suppl_4.S308

Desmet, 1992, Congenital diseases of intrahepatic bile ducts: variations on the theme „ductal plate malformation“, Hepatology, 16, 1069, 10.1002/hep.1840160434

Kassahuhn, 2005, Caroli's disease: liver resection and liver transplantation. Experience in 33 patients, Surgery, 138, 888, 10.1016/j.surg.2005.05.002

Lendorie, 2011, Caroli's disease: report of surgical options and long-term outcome of patients treated in Argentin. Multicenter study, J Gastrointest Surg, 15, 1814, 10.1007/s11605-011-1620-9

Baghbanian, 2013, Cholangiocarcinoma or Caroli disease: a case report, Gastroenterol Hepatol, 6, 214

Kasper, 2006, Primary cholangiocarcinoma in a case of Caroli's disease: a case report and literature review, Pathologe, 27, 300, 10.1007/s00292-006-0840-3

Soreide, 2004, Bile duct cysts in adults, Br J Surg, 91, 1538, 10.1002/bjs.4815

Blechacz, 2008, Cholangiocarcinoma, Clin Liver Dis, 12, 131, 10.1016/j.cld.2007.11.003

Mabrut, 2010, Management of congenital bile duct cysts, Dig Surg, 27, 12, 10.1159/000268109

Edil, 2008, Choledochal cyst disease in children and adults: a 30-year single-institution experience, J Am Coll Surg, 206, 1000, 10.1016/j.jamcollsurg.2007.12.045

Yamaguchi, 1980, Congenital choledochal cyst. Analysis of 1,433 patients in the Japanese literature, Am J Surg, 140, 653, 10.1016/0002-9610(80)90051-3

Watanabe, 1999, Bile duct cancer developed after cyst excision for choledochal cyst, J Hepatobiliary Pancreat Surg, 6, 207, 10.1007/s005340050108

Voyles, 1983, Carcinoma in choledochal cysts. Age-related incidence, Arch Surg, 118, 986, 10.1001/archsurg.1983.01390080088022

Kobayashi, 1999, Risk of bile duct carcinogenesis after excision of extrahepatic bile ducts in pancreaticobiliary maljunction, Surgery, 126, 939, 10.1016/S0039-6060(99)70036-X

Matsumoto, 2014, Hepatitis B and C virus infection is a risk factor for the development of cholangiocarcinoma, Intern Med, 53, 651, 10.2169/internalmedicine.53.1410

Donato, 2001, Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy, Cancer Causes Control, 12, 959, 10.1023/A:1013747228572

Welzel, 2007, Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study, Clin Gastroenterol Hepatol, 5, 1221, 10.1016/j.cgh.2007.05.020

Raimondo, 2007, Occult hepatitis B virus infection, J Hepatol, 46, 160, 10.1016/j.jhep.2006.10.007

Gatselis, 2007, Hepatitis B virus and intrahepatic cholangiocarcinoma, Cancer Invest, 25, 55, 10.1080/07357900601130722

Zhou, 2012, Expression of HBx protein in hepatitis B virus-infected intrahepatic cholangiocarcinoma, Hepatobiliary Pancreat Dis Int, 11, 532, 10.1016/S1499-3872(12)60219-7

Zhou, 2013, Evaluation of risk factors for extrahepatic cholangiocarcinoma: ABO blood group, hepatitis B virus and their synergism, Int J Cancer, 133, 1867, 10.1002/ijc.28196

Zhou, 2014, Hepatitis B virus infection and intrahepatic cholangioacrcinoma, World J Gastroenterol, 20, 5721, 10.3748/wjg.v20.i19.5721

Li, 2014, OcculthepatitisBvirusinfection in chinese cryptogenic intrahepatic cholangiocarcinomapatientpopulation, J Clin Gastroenterol, 48, 878, 10.1097/MCG.0000000000000058

Yin, 1998, Detection of hepatitis C virus RNA sequences in hepatic portal cholangiocarcinoma tissue by reverse transcription polymerase chain reaction, Chin Med J, 111, 1068

Tao, 2010, Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case-control study in China, Liver Int, 30, 215, 10.1111/j.1478-3231.2009.02149.x

Wu, 2013, Characteristics of intrahepatic cholangiocarcinoma in patients with hepatitis B virus infection: clinicopathologic study of resected tumours, J Viral Hepat, 20, 306, 10.1111/jvh.12005

Wu, 2009, Biliary intraepithelial neoplasia in patients without chronic biliary disease: analysis of liver explants with alcoholic cirrhosis, hepatitis C infection, and noncirrhotic liver diseases, Cancer, 115, 4564, 10.1002/cncr.24471

Chen, 2005, Effect of hepatitis C virus core protein on modulation of cellular proliferation and apoptosis in hilar cholangiocarcinoma, Hepatobiliary Pancreat Dis Int, 4, 71

Li, 2010, Epithelialmesenchymal transition induced by hepatitis C virus core protein in cholangiocarcinoma, Ann Surg Oncol, 17, 1937, 10.1245/s10434-010-0925-3

Lu, 2000, Detection of hepatitis C virus RNA sequences in cholangiocarcinomas in Chinese and American patients, Chin Med J, 113, 1138

Wang, 1998, Expression and significance of HBV genes and their antigens in human primary intrahepatic cholangiocarcinoma, World J Gastroenterol, 4, 392, 10.3748/wjg.v4.i5.392

Shaib, 2007, Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study, Am J Gastroenterol, 102, 1016, 10.1111/j.1572-0241.2007.01104.x

Ralphs, 2013, The role of the hepatitis viruses in cholangiocarcinoma, J Viral Hepat, 20, 297, 10.1111/jvh.12093

Watanapa, 2002, Liver fluke-associated cholangiocarcinoma, Br J Surg, 89, 962, 10.1046/j.1365-2168.2002.02143.x

Haswell-Elkins, 1994, Liver fluke infection and cholangiocarcinoma: model of endogenous nitric oxide and extragastric nitrosation in human carcinogenesis, Mutat Res, 305, 241, 10.1016/0027-5107(94)90244-5

Bhamarapravati, 1978, Liver changes in hamsters infected with a liver fluke of man, Opisthorchis viverrini, Am J Trop Med Hyg, 27, 787, 10.4269/ajtmh.1978.27.787

Parkin, 1991, Liver cancer in Thailand. I. A case-control study of cholangiocarcinoma, Int J Cancer, 48, 323, 10.1002/ijc.2910480302

Choi, 2006, Cholangiocarcinoma and Clonorchis sinensis infection: a casecontrol study in Korea, J Hepatol, 44, 1066, 10.1016/j.jhep.2005.11.040

Lim, 2006, Clonorchis sinensis infection and increasing risk of cholangiocarcinoma in the Republic of Korea, Am J Trop Med Hyg, 75, 93, 10.4269/ajtmh.2006.75.93

Shin, 1996, Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea, Int J Epidemiol, 25, 933, 10.1093/ije/25.5.933

Cheng, 2007, Predictive factors for prognosis of hilar cholangiocarcinoma: postresection radiotherapy improves survival, Eur J Surg Oncol, 33, 202, 10.1016/j.ejso.2006.09.033

Sripa, 2007, Liver fluke induces cholangiocarcinoma, PLoS Med, 4, 1148, 10.1371/journal.pmed.0040201

Vennerwald, 2009, Helminths and malignancy, Parasite Immunol, 31, 686, 10.1111/j.1365-3024.2009.01163.x

Wiwanitkit, 2009, Peticides, fresh water fish, liver flukes and nitrosamine: a story of cholangiocarcinoma development in thailand, Asian Pac J Cancer Prev, 10, 939

Kato, 1987, Increased risk of death in thorotrast-exposed patients during the late follow-up period, Jpn J Cancer Res, 78, 1187

Brandi, 2013, Asbestos: a hidden player behind the cholangiocarcinoma increase? Findings from a case control analysis, Cancer Causes Control, 24, 911, 10.1007/s10552-013-0167-3

Shaib, 2005, Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study, Gastroenterology, 128, 620, 10.1053/j.gastro.2004.12.048

Grainge, 2009, The antecedents of biliary cancer: a primary care case-control study in the United Kingdom, Br J Cancer, 100, 178, 10.1038/sj.bjc.6604765

Sorensen, 1998, Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark, Hepatology, 28, 921, 10.1002/hep.510280404

Blechacz, 2011, Clinical diagnosis and staging of cholangiocarcinoma, Nat Rev Gastroenterol Hepatol, 8, 512, 10.1038/nrgastro.2011.131

Bismuth, 1994

Paul, 2011, Am Surg, 77, 1695, 10.1177/000313481107701246

Sobin, 2009

Cho, 2012, Surgical outcomes and predicting factors of curative resection in patients with hilar cholangiocarcinoma: 10-year single-institution experience, J Gastrointest Surg, 16, 1672, 10.1007/s11605-012-1960-0

Jarnagin, 2001, Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma, Ann Surg, 234, 507, 10.1097/00000658-200110000-00010

Deoliveira, 2011, New staging system and a registry for perihilar cholangiocarcinoma, Hepatology, 53, 1363, 10.1002/hep.24227

Chaiteerakij, 2014, A new clinically based staging system for perihilar cholangiocarcinoma, Am J Gastroenterol, 109, 1881, 10.1038/ajg.2014.327